Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,768 INR
Change Today +7.00 / 0.40%
Volume 111.7K
CDH On Other Exchanges
Natl India
As of 7:07 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Zydus Tower

Satellite Cross Roads

Ahmedabad, 380015


Phone: 91 79 2686 8100

Fax: 91 79 2686 2365

Cadila Healthcare Limited discovers, develops, manufactures, and markets a range of healthcare products worldwide. It provides its products in various forms, including formulations, injectable, aerosols, ointments, vaccines, biologics, active pharmaceutical ingredients, etc. The company offers products in the areas of cardiovascular, gastro intestinal, respiratory, women’s healthcare, pain management, CNS, anti-infective, oncology, neuroscience, dermatology, nephrology, and chronic/lifestyle primarily under the Aten, Ocid, Deriphyllin, Pantodac, Atorva, Nucoxia, and Mifegest brands. It also provides consumer healthcare and wellness products, such as Sugar Free Gold, a sweetener; Sugar Free Natura, a sucralose based sugar substitute; Sugar Free D’lite, a healthy drink; Nutralite, a cholesterol-free table spread; and Actilife, a nutritional milk additive for adults, as well as skincare products comprising scrubs, peel-off, face wash, and soaps under its Everyuth and Dermacare brands. In addition, the company researches and develops a pipeline of 19 biologics comprising 17 biosimilars and 2 novel biological products; new drugs in cardio-metabolic, inflammation, pain, and oncology therapeutic areas; novel drug delivery systems; molecules for DMF filing and NPD molecules; and generic products, as well as solid orals, pulmonary, parenterals, suppository, topical, and oncology products. Further, it provides animal healthcare products comprising drugs, feed supplements, and vaccines for livestock, companion animals, and poultry. Additionally, the company develops vaccines that are designed to address infectious diseases, including next-generation influenza, measles-mumps-rubella-varicella, typhoid, DPT-HiB, hepatitis-B, hepatitis-A, hepatitis-E, Japanese encephalitis, and HPV. It has strategic out-licensing deal with Abbott Laboratories for the commercial supply of products. The company was founded in 1952 and is headquartered in Ahmedabad, India.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDH:IN 1,767.50 INR +7.00

CDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cipla Ltd/India 637.65 INR -26.30
Glenmark Pharmaceuticals Ltd 896.40 INR 0.00
Piramal Enterprises Ltd 949.95 INR -5.20
Torrent Pharmaceuticals Ltd 1,218 INR +3.75
Wockhardt Ltd 1,625 INR -76.80
View Industry Companies

Industry Analysis


Industry Average

Valuation CDH Industry Range
Price/Earnings 34.3x
Price/Sales 4.3x
Price/Book 9.1x
Price/Cash Flow 27.4x
TEV/Sales 4.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADILA HEALTHCARE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at